Some biotech companies are offering a new way to soften the shock of drug prices: Insurers pay only if the patient improves

Quick Read

Overprescribed

April 3, 2019

High cost isn’t America’s only drug problem. The pharmaceutical industry has followed a brilliant two-pronged strategy to maximize its profits: raise prices and increase consumption of medications

Quick Read

With much fanfare, federal officials required hospitals nationwide this year to post their “list” prices online. But it’s not yet clear how many are doing it, even as the government has taken the rare step of asking consumers to monitor hospital compliance.

Quick Read

Tens of millions of Americans undergo surgery each year. They expect their surgeon to be in the operating room for the entire procedure. That’s not always the case — the surgeon may have two operations scheduled at the same time

Quick Read

Tired of regulatory confusion and a lack of funding, some US researchers are taking their gene-edited livestock abroad

Quick Read

Bob Field was set to kick off his second course of BCG — a potent immunotherapy that treats his fast-growing bladder cancer. Instead, the New York City banking executive got a call from his urologist’s office, canceling that week’s appointment

Quick Read

Big pharma is partnering with influencers to sell new drugs and medical devices

Quick Read

The federal government’s new rule requiring hospitals to post prices for their services is intended to allow patients to shop around and compare prices, a step toward price transparency that has generated praise and skepticism

Quick Read